JPRN-UMIN000038483Not yet recruiting未知
Add on Effect of Fesoterodine and Vibegron for Male Overactive Bladder Treated with Tadalafil Multicenter Randomized Comparative Study - FAVORITE Study
Department of Renal and Urologic Surgery, Asahikawa Medical University0 sites280 target enrollmentStarted: December 31, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 280
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to ot applicable (—)
- Sex
- Male
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Over 100ml of postvoid residual
Investigators
Similar Trials
Not yet recruiting
Phase 4
A comparison of medicines used for overactive bladder (fesoterodine vs mirabegron vs solifenacin)CTRI/2024/02/063069VYOMA DESAI
Completed
Not Applicable
rodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladderneurogenic bladderJPRN-UMIN000037584Dokkyo Medical University77
Completed
Not Applicable
Effect of Fexofenadine/Pseudoephedrine combination tablet on Nasal Obstruction in Patients with Allergic Rhinitisallergic rhinitisJPRN-UMIN000041845Tottori University24
Completed
Not Applicable
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drugBronchial asthmaJPRN-UMIN000003805JA Tohno Kousei Hospital40
Unknown
Phase 4
Comparison of fesoterodine and mirabegron in the treatment of female overactive baldder patients with urgency incontinence: A randomized, prospective study (Feminine study)overactive bladderJPRN-UMIN000024442Department of urology, Nagoya University Graduate School of Medicine300